Aziz Maksoud is a Cardiology physician. OpenAlex indexes 36 publications with 382 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
9350 E 35th St N
Ste 101
Wichita, KS 672262019
Telephone
316-265-1308Provider last certified this registry record 23 Mar 2021.
Industry payments
30 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Abbott LaboratoriesProgram year202515 payments
- Medtronic, Inc.Program year202514 payments
- Siemens Medical Solutions USA, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
75.2%Statin20.1%Atorvastatin Calcium73%Rosuvastatin Calcium20%Simvastatin7%Pravastatin Sodium1%Part D<11 patientsBeta blocker15.9%Metoprolol Tartrate59%Carvedilol29%Metoprolol Succinate9%Sotalol3%Atenolol2%Part D<11 patients+ 19 more classes in this area
Blood & clotting
19.7%P2Y12 inhibitor9.5%Clopidogrel93%Brilinta5%Prasugrel Hcl2%Part D<11 patientsFactor Xa inhibitor9.1%Eliquis87%Xarelto13%Part D≥260 patients+ 3 more classes in this area
Metabolism & gastrointestinal
4.8%Proton pump inhibitor3.2%Pantoprazole Sodium96%Omeprazole4%Part D<11 patientsPotassium supplement1.7%Potassium Chloride85%Klor-Con M2015%Part D≥65 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- 1-Month or 3-Month DAPT in Women and Men at High Bleeding Risk Undergoing PCI
JACC: Cardiovascular Interventions
2025 - Predictors of Variability in Coronary Flow Reserve and Microvascular Resistance Measurement Using the Bolus Thermodilution Technique
Catheterization and Cardiovascular Interventions
2025 - TCT-996 One-versus three-month DAPT in High Bleeding Risk Patients With or Without Baseline Anemia Undergoing PCI
Journal of the American College of Cardiology
2025
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”